Form 4 for LMAT LEMAITRE VASCULAR INC
Accepted 2023-11-28 00:00:00 ET · period of report 2023-11-27 · accession 0001437749-23-033115 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-11-28 | 2023-11-27 | LMAT | O'Connor John James | Dir | M - OptEx | $23.56 | +7,500 | 56.5K | +15% | +$176.7K |
| D | 2023-11-28 | 2023-11-27 | LMAT | O'Connor John James | Dir | M - OptEx | $0.00 | -7,500 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-27 | M | A | 7,500 | $23.56 | 56,454 | D | — | — | (F1) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-11-27 | M | D | 7,500 | $0.00 | 0 | D | $23.56 · 2018-12-19 to 2023-12-19 | 7,500 Common Stock | (F2) This option is exercisable and vests over a five-year period at a rate of 1/3 on the first anniversary of the date listed in the table, and the balance vests in equal annual installments over the remaining three years. |